1381 related articles for article (PubMed ID: 32169778)
1. Multi-stimuli responsive mesoporous silica-coated carbon nanoparticles for chemo-photothermal therapy of tumor.
Lu H; Zhao Q; Wang X; Mao Y; Chen C; Gao Y; Sun C; Wang S
Colloids Surf B Biointerfaces; 2020 Jun; 190():110941. PubMed ID: 32169778
[TBL] [Abstract][Full Text] [Related]
2. Triple stimuli-responsive ZnO quantum dots-conjugated hollow mesoporous carbon nanoplatform for NIR-induced dual model antitumor therapy.
Feng S; Mao Y; Wang X; Zhou M; Lu H; Zhao Q; Wang S
J Colloid Interface Sci; 2020 Feb; 559():51-64. PubMed ID: 31610305
[TBL] [Abstract][Full Text] [Related]
3. Multi-stimuli responsive mesoporous carbon nano-platform gated by human serum albumin for cancer thermo-chemotherapy.
Zhao Q; Wang X; Yang M; Li X; Mao Y; Guan X; Di D; Wang S
Colloids Surf B Biointerfaces; 2019 Dec; 184():110532. PubMed ID: 31590051
[TBL] [Abstract][Full Text] [Related]
4. Multi-stimuli responsive nanosystem modified by tumor-targeted carbon dots for chemophototherapy synergistic therapy.
Wang X; Li X; Mao Y; Wang D; Zhao Q; Wang S
J Colloid Interface Sci; 2019 Sep; 552():639-650. PubMed ID: 31173992
[TBL] [Abstract][Full Text] [Related]
5. Mesoporous Carbon Nanoparticles as Multi-functional Carriers for Cancer Therapy Compared with Mesoporous Silica Nanoparticles.
Zhou M; Zhao Q; Wu Y; Feng S; Wang D; Zhang Y; Wang S
AAPS PharmSciTech; 2020 Jan; 21(2):42. PubMed ID: 31897882
[TBL] [Abstract][Full Text] [Related]
6. Fabrication of Rhenium Disulfide/Mesoporous Silica Core-Shell Nanoparticles for a pH-Responsive Drug Release and Combined Chemo-Photothermal Therapy.
Na H; Carrier J; Oyon S; Lai CY
ACS Appl Bio Mater; 2024 May; 7(5):3337-3345. PubMed ID: 38700956
[TBL] [Abstract][Full Text] [Related]
7. Fabricating polydopamine-coated MoSe
Chai S; Kan S; Sun R; Zhou R; Sun Y; Chen W; Yu B
Int J Nanomedicine; 2018; 13():7607-7621. PubMed ID: 30510420
[TBL] [Abstract][Full Text] [Related]
8. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy.
Gautam M; Thapa RK; Poudel BK; Gupta B; Ruttala HB; Nguyen HT; Soe ZC; Ou W; Poudel K; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2019 Apr; 88():448-461. PubMed ID: 30818051
[TBL] [Abstract][Full Text] [Related]
9. Hollow mesoporous carbon as a near-infrared absorbing carrier compared with mesoporous carbon nanoparticles for chemo-photothermal therapy.
Li X; Yan Y; Lin Y; Jiao J; Wang D; Di D; Zhang Y; Jiang T; Zhao Q; Wang S
J Colloid Interface Sci; 2017 May; 494():159-169. PubMed ID: 28157634
[TBL] [Abstract][Full Text] [Related]
10. Graphene quantum dots-gated hollow mesoporous carbon nanoplatform for targeting drug delivery and synergistic chemo-photothermal therapy.
Fang J; Liu Y; Chen Y; Ouyang D; Yang G; Yu T
Int J Nanomedicine; 2018; 13():5991-6007. PubMed ID: 30323587
[TBL] [Abstract][Full Text] [Related]
11. A multifunctional nanoplatform based on MoS
Yang Y; Wu J; Bremner DH; Niu S; Li Y; Zhang X; Xie X; Zhu LM
Colloids Surf B Biointerfaces; 2020 Jan; 185():110585. PubMed ID: 31683203
[TBL] [Abstract][Full Text] [Related]
12. Gold nanoparticles modified hollow carbon system for dual-responsive release and chemo-photothermal synergistic therapy of tumor.
Zhao Q; Yang Y; Wang H; Lei W; Liu Y; Wang S
J Colloid Interface Sci; 2019 Oct; 554():239-249. PubMed ID: 31301524
[TBL] [Abstract][Full Text] [Related]
13. Gold nanoparticle-gated mesoporous silica as redox-triggered drug delivery for chemo-photothermal synergistic therapy.
Yang Y; Lin Y; Di D; Zhang X; Wang D; Zhao Q; Wang S
J Colloid Interface Sci; 2017 Dec; 508():323-331. PubMed ID: 28843922
[TBL] [Abstract][Full Text] [Related]
14. The Graphene Quantum Dots Gated Nanoplatform for Photothermal-Enhanced Synergetic Tumor Therapy.
Wang L; Wang W; Wang Y; Tao W; Hou T; Cai D; Liu L; Liu C; Jiang K; Lin J; Zhang Y; Zhu W; Han C
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338360
[TBL] [Abstract][Full Text] [Related]
15. Polydopamine-coated mesoporous silica nanoparticles for multi-responsive drug delivery and combined chemo-photothermal therapy.
Lei W; Sun C; Jiang T; Gao Y; Yang Y; Zhao Q; Wang S
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110103. PubMed ID: 31546357
[TBL] [Abstract][Full Text] [Related]
16. NIR-triggered release of DOX from sophorolipid-coated mesoporous carbon nanoparticles with the phase-change material 1-tetradecanol to treat MCF-7/ADR cells.
Hussain A; Guo S
J Mater Chem B; 2019 Feb; 7(6):974-985. PubMed ID: 32255102
[TBL] [Abstract][Full Text] [Related]
17. Mesoporous platinum nanoparticle-based nanoplatforms for combined chemo-photothermal breast cancer therapy.
Fu B; Dang M; Tao J; Li Y; Tang Y
J Colloid Interface Sci; 2020 Jun; 570():197-204. PubMed ID: 32151829
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles.
Bagheri E; Alibolandi M; Abnous K; Taghdisi SM; Ramezani M
J Mater Chem B; 2021 Feb; 9(5):1351-1363. PubMed ID: 33447840
[TBL] [Abstract][Full Text] [Related]
19. Dual-responsive molybdenum disulfide/copper sulfide-based delivery systems for enhanced chemo-photothermal therapy.
Zhang X; Wu J; Williams GR; Yang Y; Niu S; Qian Q; Zhu LM
J Colloid Interface Sci; 2019 Mar; 539():433-441. PubMed ID: 30599399
[TBL] [Abstract][Full Text] [Related]
20. Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells.
Tran VA; Vo VG; Shim K; Lee SW; An SSA
Int J Nanomedicine; 2020; 15():7667-7685. PubMed ID: 33116494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
